Authors


Evangelia Vlachou, MD

Latest:

Enfortumab Vedotin With or Without Pembrolizumab Delivers Promising Responses for Upper Tract Urothelial Cancer

Enfortumab vedotin with or without pembrolizumab offers disease control benefits for patients with upper tract urothelial cancer, said Evangelia Vlachou, MD, of Johns Hopkins Medicine.


Debasish Mohapatra, MD

Latest:

Clinical Profile of COVID-19 Infection in Postvaccination Individuals

This article describes the findings of an observational study carried out in India to examine the clinical profile of individuals detected to be COVID-19 positive post vaccination.



Zachary Villaverde, BS

Latest:

Physiologic Insulin Resensitization Lowers Cost in Patients With Diabetes and Kidney Disease

Patients with diabetes and chronic kidney disease receiving physiologic insulin resensitization had much lower annual costs of care than similar patients not receiving it.


Chung-Ting Chen, MD, MS

Latest:

Association Between Screening for Suspected COVID-19 Cases and Outcomes of Patients Revisiting the Emergency Department

Patients who revisit the emergency department shortly after discharge are at high risk for complications and death, exacerbated by COVID-19 screening workload. Detection efforts impact outcomes.


Andrea Millman, MA

Latest:

Primary Care Video and Telephone Telemedicine During the COVID-19 Pandemic: Treatment and Follow-up Health Care Utilization

Telephone visits may offer a simple and convenient option to address patient primary care needs without raising safety concerns.



Devin M. Mann, MD

Latest:

The “New” New Normal: Changes in Telemedicine Utilization Since COVID-19

Telemedicine utilization has declined since the peak of the COVID-19 pandemic, but non–primary care specialties continue to see an increase in moderate- and high-complexity telemedicine visits.


Derek van Amerongen, MD, MS

Latest:

Concluding Remarks: Impact of Alzheimer Disease, Promising Treatments in Development, and Future Outlook

Looking to the future of Alzheimer disease treatment, the panel discusses key takeaways on the evolving therapeutic landscape.


Mark Supino, MD

Latest:

People Experiencing Homelessness in Miami: Insurance Enrollment Rates, Hypertension Trends

People experiencing homelessness face significant barriers to health care access, leading to higher rates of hypertension even among those with health insurance.


Heather M. Byrne, MPA-HSA, CNMT

Latest:

Eliminating Defects in Value: Turnaround of an MSSP ACO

A health system transformational leadership framework and management system made visible and eliminated defects in value and was associated with reduced annual Medicare expenditures and increased quality between 2017 and 2020.


Chris Wallick, PharmD, MS

Latest:

Baloxavir vs Oseltamivir: Reduced Utilization and Costs in Influenza

Baloxavir, compared with oseltamivir, was associated with lower health care resource utilization and costs in patients with influenza, particularly those at high risk of secondary complications.


Kandice A. Kapinos, PhD

Latest:

Differences in Savings and Quality by Type of ACO Model

2016-2018 Next Generation Accountable Care Organization (ACO) and Medicare Shared Savings Program cost and quality data show similar performance, suggesting that increasing financial risk to health systems may not affect performance.


Georgianna Mann, PhD

Latest:

Impact of Food Affordability on Diabetes-Related Preventable Hospitalization

Medicaid enrollees residing in counties with greater food affordability had lower odds of preventable hospitalization related to diabetes.


Mark Bensink, PhD

Latest:

Estimating the Economic Burden of Migraine on US Employers

The Migraine Impact Model is an interactive calculator that estimates migraine prevalence within a workforce and the associated economic burden of migraine on the employer.


Oluwatoyin Olubiyi, MD, MPH

Latest:

The Implementation of Opioid Prescribing Report Cards in Medicaid Managed Care: A Community Quality Collaborative

This article describes the Philadelphia Medicaid Opioid Prescribing Initiative that was launched by a multidisciplinary team and mailed local Medicaid providers individualized prescribing report cards.


Wesley Barker, MS

Latest:

Integrating Third-Party Apps With Electronic Health Records to Support COVID-19 Response

This study observed a rapid increase in the integration of telehealth- and COVID-19–related apps with electronic health records during the COVID-19 pandemic.


David L. Swerdlow, MD

Latest:

Hospital Discharge Diagnosis Position: Impact on Adult Pneumonia Burden Estimates

Disease burden estimates of pneumonia-associated hospitalizations are more sensitive when including pneumonia coded in any diagnosis field vs in only the first discharge diagnosis field.


Nathan W. Carroll, PhD

Latest:

Improving Risk Stratification Using AI and Social Determinants of Health

Prediction models combining claims data with social determinants of health and additional, more-timely data sources using artificial intelligence (AI) can better identify individuals with the highest future medical spending.


GL Zunker
GL Zunker

Latest:

Contributor: Why Hasn’t Value-Based Care Delivered on Its Promise at Scale?

To deliver on the promise of value-based care, organizations need to return to the fundamental objective: to deliver high-quality, affordable care to our communities.


Justin Puckett, BA

Latest:

Financial Incentives Tied to Medicare Star Ratings: Impact on Influenza Vaccination Uptake in Medicare Beneficiaries

Influenza vaccine uptake improved among Medicare Advantage enrollees when influenza vaccination was introduced as a performance metric in Medicare star ratings and accompanying bonus payments.


Robert Groves, MD

Latest:

Thoughts on Redesigning Health Care: Aligning Incentives to Drive Innovation

An editorial in response to the editor-in-chief’s December 2021 letter describes how a payer continues to push the limits of innovation through shared learnings and collaboration.


S. Ryan Greysen, MD

Latest:

An Accelerated Hospital Observation Pathway to Reduce Length of Stay for Patients With COVID-19

For select patients hospitalized due to COVID-19, an academic urban hospital implemented an observation pathway that incorporated mobile health technology, reducing hospital length of stay by more than 2 days.


Emily Brickell, PsyD

Latest:

Care Management Improves Total Cost of Care for Patients With Dementia

Compared with usual care, a dementia care management program improved various cost of care and utilization metrics in a Medicare managed care population at 12 months.


Jeff T. Mohl, PhD

Latest:

Health Systems and Telemedicine Adoption for Diabetes and Hypertension Care

Small practices reduced their use of telemedicine during early stages of the COVID-19 pandemic. Technical support may help expand and maintain telemedicine in small practices.


Robin Danek, PhD, MPH

Latest:

Inpatient Opioid Receipt and Care Experiences for Vaginal Delivery

The objective of this study was to examine the relationship between inpatient opioid receipt and care experiences of women hospitalized for vaginal delivery.


Art Jones, MD

Latest:

Improving Risk Stratification Using AI and Social Determinants of Health

Prediction models combining claims data with social determinants of health and additional, more-timely data sources using artificial intelligence (AI) can better identify individuals with the highest future medical spending.


Christina Downey, MD

Latest:

To Preserve Access to Care, Congress Must Repair Medicare’s Broken Payment System

The author, chair of the Government Affairs Committee with the American College of Rheumatology, calls for support for efforts in Congress to reform the Physician Fee Schedule.


Janet S. Lee, MS

Latest:

Telehealth Transitional Care and 30-Day Readmission During the COVID-19 Pandemic

This study found that the dramatic shift from face-to-face posthospital transitional care to telehealth did not affect 30-day readmission or mortality during the COVID-19 pandemic.


Eric Tichy, PharmD, MBA, BCPS, FCCP, FAST

Latest:

Private Label Biosimilars

The expert panel discusses the greater potential for private label biosimilars.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo